| THBD |
THBD, THRM: Thrombomodulin precursor |
ALB |
ALB: Uncharacterized protein ALB |
13.860 |
Evidence |
|
| FGA |
IPI00021885 |
HGFAC |
HGFAC: Hepatocyte growth factor activator precursor |
13.860 |
Evidence |
|
| IL2RA |
IL2RA: Interleukin-2 receptor alpha chain precursor |
CFI |
CFI, IF: Complement factor I precursor |
13.860 |
Evidence |
|
| TIMP1 |
TIMP1, CLGI, TIMP: Metalloproteinase inhibitor 1 precursor |
CMA1 |
CMA1, CYH, CYM: Chymase precursor |
13.860 |
Evidence |
|
| SLIT2 |
SLIT2, SLIL3: Slit homolog 2 protein precursor |
CGA |
CGA: Glycoprotein hormones alpha chain precursor |
13.860 |
Evidence |
|
| JAK2 |
JAK2: Tyrosine-protein kinase JAK2 |
PASK |
PASK, KIAA0135: PAS domain-containing serine/threonine-protein kinase |
13.860 |
Evidence |
|
| JAK2 |
JAK2: Tyrosine-protein kinase JAK2 |
PRKAA1 |
IPI00011891 |
13.860 |
Evidence |
|
| FRS3 |
FRS3: Fibroblast growth factor receptor substrate 3 |
CTTN |
CTTN, EMS1: Src substrate cortactin |
13.860 |
Evidence |
|
| PLD2 |
PLD2: Phospholipase D2 |
SH2D2A |
SH2D2A, SCAP, TSAD, VRAP: SH2 domain-containing protein 2A |
13.860 |
Evidence |
|
| IKBKB |
IKBKB, IKKB: Inhibitor of nuclear factor kappa-B kinase subunit beta |
PRKCI |
PRKCI, DXS1179E: Protein kinase C iota type |
13.860 |
Evidence |
|
| SOCS3 |
SOCS3, CIS3, SSI3: Suppressor of cytokine signaling 3 |
IRS2 |
IRS2: Insulin receptor substrate 2 |
13.860 |
Evidence |
|
| SOCS3 |
SOCS3, CIS3, SSI3: Suppressor of cytokine signaling 3 |
STAT6 |
STAT6: Signal transducer and activator of transcription 6 |
13.860 |
Evidence |
|
| SOCS3 |
SOCS3, CIS3, SSI3: Suppressor of cytokine signaling 3 |
VAV1 |
VAV1, VAV: Proto-oncogene vav |
13.860 |
Evidence |
|
| APS |
SH2B2, APS: SH2B adapter protein 2 |
SH3BP2 |
SH3BP2: Uncharacterized protein SH3BP2 |
13.860 |
Evidence |
|
| WASL |
WASL: Neural Wiskott-Aldrich syndrome protein |
SRC |
SRC, SRC1: Proto-oncogene tyrosine-protein kinase Src |
13.860 |
Evidence |
|
| TLR4 |
TLR4: Toll-like receptor 4 precursor |
FADD |
FADD, MORT1: Protein FADD |
13.860 |
Evidence |
|
| PABPC1 |
PABPC1, PAB1, PABP1, PABPC2: Polyadenylate-binding protein 1 |
EIF5 |
EIF5: Eukaryotic translation initiation factor 5 |
13.840 |
Evidence |
|
| FOSL2 |
FOSL2, FRA2: Fos-related antigen 2 |
REST |
REST, NRSF, XBR: RE1-silencing transcription factor |
13.820 |
Evidence |
|
| FOSL2 |
FOSL2, FRA2: Fos-related antigen 2 |
RIPK1 |
RIPK1, RIP: Receptor-interacting serine/threonine-protein kinase 1 |
13.820 |
Evidence |
|
| FGB |
FGB: Fibrinogen beta chain precursor [Contains: Fibrinopeptide B] |
ASPN |
ASPN: ASPN protein |
13.820 |
Evidence |
|
| FOS |
FOS, G0S7: Proto-oncogene protein c-fos |
RIPK1 |
RIPK1, RIP: Receptor-interacting serine/threonine-protein kinase 1 |
13.820 |
Evidence |
|
| RAC2 |
RAC2: Ras-related C3 botulinum toxin substrate 2 precursor |
SMAD3 |
SMAD3, MADH3: Mothers against decapentaplegic homolog 3 |
13.810 |
Evidence |
|
| EXOSC2 |
EXOSC2, RRP4: Exosome complex exonuclease RRP4 |
EXOSC5 |
EXOSC5, CML28, RRP46: Exosome complex exonuclease RRP46 |
13.790 |
Evidence |
O
|
| HIST1H2BG |
HIST1H2BC, H2BFL, HIST1H2BE, H2BFH, HIST1H2BF, H2BFG, HIST1H2BG, H2BFA, HIST1H2B |
HIST2H2BE |
HIST2H2BE, H2BFQ: Histone H2B type 2-E |
13.790 |
Evidence |
|
| ACTG1 |
ACTR2, ARP2: Actin-related protein 2 |
CCT8 |
CCT8: Uncharacterized protein CCT8 |
13.790 |
Evidence |
|